4//SEC Filing
Khan Najat 4
Accession 0001601830-24-000106
CIK 0001601830other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 5:12 PM ET
Size
7.3 KB
Accession
0001601830-24-000106
Insider Transaction Report
Form 4
Khan Najat
DirectorChief R&D Commercial Officer
Transactions
- Award
Class A Common Stock
2024-08-01+496,972→ 496,972 total - Award
Stock Option (Right to Buy)
2024-08-01+993,944→ 993,944 totalExercise: $7.34Exp: 2034-08-01→ Class A Common Stock (993,944 underlying)
Footnotes (2)
- [F1]This RSU vests as to one fourth (1/4th) of the units subject to the RSU on August 15, 2025 and one sixteenth (1/16th) every three months thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.
- [F2]This option vests as to one fourth (1/4th) of the shares subject to the option on July 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0002020969
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 5:12 PM ET
- Size
- 7.3 KB